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Edited by Maurice MontalAbstract The channel activity of colicin E1 was studied in
planar lipid bilayers and liposomes. Colicin E1 pore-forming
activity was found to depend on the curvature of the lipid bilayer,
as judged by the eﬀect on channel activity of curvature-
modulating agents. In particular, the colicin-induced trans-
membrane current was augmented by lysophosphatidylcholine
and reduced by oleic acid, agents promoting positive and negative
membrane curvature, respectively. The data obtained imply
direct involvement of lipids in the formation of colicin E1-
induced pore walls. It is inferred that the toroidal pore model
previously validated for small antimicrobial peptides is applica-
ble to colicin E1, a large protein that contains ten a-helices in its
pore-forming domain.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Colicin E1 belongs to a group of water-soluble ‘‘membrane-
active’’ proteins that can interact with lipid membranes
through conformational changes [1–3]. These interactions re-
sult in the formation of ion-conducting pores in lipid bilayers
[4–6]. It has been shown that pore formation by the closely
related colicins Ia and A is accompanied by translocation of a
substantial part of the colicin polypeptide across the mem-
brane [7–11]. Moreover, hydrophilic proteins inserted in the
translocated segment of the pore-forming colicin are them-* Corresponding author. Fax: +7095-939-31-81.
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Abbreviations: BLM, bilayer lipid membrane; DPhPC, diphytano-
ylphosphatidylcholine; DPhPG, diphytanoylphosphatidylglycerol;
DPhPS, diphytanoylphosphatidylserine; DOPC, dioleoylphos-
phatidylcholine; DOPG, dioleoylphosphatidylglycerol; DOPE,
dioleoylphosphatidylethanolamine; M-LPC, myristoyl-lysophosphati-
dylcholine; O-LPC, oleoyl-lysophosphatidylcholine; OA, oleic acid;
9,10-BrPC, 9,10-dibromo-palmitoylphosphatidylcholine; CF, carboxy-
ﬂuorescein; SC, spontaneous curvature
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doi:10.1016/j.febslet.2004.09.016selves translocated and are functional on the opposite side of
the bilayer [12]. However, the structure of the pore and the
mechanism of translocation remain obscure.
Progress in the research of the action of antimicrobial pep-
tides on membranes has led to the formulation of the model of
a toroidal lipid pore [13], involving direct participation of
lipids in the formation of the pore [14–25]. An essential feature
of this model is that a wall of the pore consists not only of
peptides but also of lipid headgroups, which line the pore from
one side of the membrane surface to the other, thereby forming
a structure of high positive curvature.
The toroidal pore mechanism has been considered for a se-
ries of small antimicrobial peptides, e.g., magainin [16], mel-
ittin [23], pleurocidin [26], the phytotoxic lipopeptide
syringomycin E [27], the human cathelicidin antimicrobial
peptide LL-37 [28], and the hagﬁsh cathelicidin antimicrobial
peptide [29]. The major evidence in favor of toroidal pore
formation by the peptides derives from the sensitivity of their
pore-forming activity to the curvature of the target lipid bi-
layer membranes. Lipids with positive spontaneous curvature
(SC) stimulate, while lipids having negative SC inhibit the
formation of pores by magainin and syringomycin [16,27]. The
value of the SC, determined by the ratio of the cross-sectional
areas of headgroup to acyl chain moieties [30,31], characterizes
the ability of lipids to form non-bilayer structures.
The formation of a structure closely related to a toroidal
pore, with highly bent transient lipidic connections between
fusing membranes (the so-called fusion stalks) is implicated in
the process of membrane fusion [32–35]. In particular, it has
been shown that the agents having an ability to modify the SC
of a planar lipid bilayer, lysophosphatidylcholine and oleic
acid (OA), inducers of positive and negative SC, respectively,
inhibit and stimulate the fusion of cells with a target planar
membrane [33]. The electrical breakdown of planar bilayer li-
pid membrane (BLM) is also thought to occur through ex-
pansion of positively curved toroidal-type lipidic pores [36].
The toroidal pore concept has also been proposed to be
involved in the mechanism of action of large toxins belonging
to a group of actinoporins, e.g., equinatoxin II [37] and sti-
cholysins [38,39], although the inﬂuence of membrane curva-
ture has shown to be opposite for sticholysin [38] compared to
magainin [16]. The authors suggest that the presence of a mi-
nor amount of cardiolipin, a strong inducer of negative SC,ation of European Biochemical Societies.
206 A.A. Sobko et al. / FEBS Letters 576 (2004) 205–210augments the eﬃciency of toxin pore formation because of the
presence of a negative curvature region in the plane of the
membrane around the toroidal pore. Recently, evidence has
been reported pointing to the formation of toroidal-shaped
pores by the pro-apoptotic proteins Bax [40,41] and tBid [42],
though the data on the relationship between the bilayer SC and
the membrane-permeabilizing potency of these proteins are
rather diverse [41–44].
In the present study, we used agents that modulate the
membrane SC in order to test their eﬀect on colicin E1 channel
function. It was shown that lysophosphatidylcholine promoted
the colicin channel activity, whereas OA reduced it. In addi-
tion, experiments with membranes of diﬀerent lipid composi-
tions revealed a correlation between the membrane
permeabilizing potency of colicin and the bending propensity
of a bilayer. Thus, the data obtained here point to the rele-
vance of the toroidal pore mechanism to the process of colicin
E1 channel formation.Fig. 1. Eﬀect of 10 lM M-LPC (panel A) or 10 lM OA (panel B) on
the colicin E1-induced current across a planar lipid bilayer. The
membrane was formed from a squalene solution of DPhPC/DPhPG
(70/30%). The buﬀer solution was 10 mM b-alanine and 120 mM KCl,
pH 4.0. Initial voltage was 60 mV. Inset to panel B. Dependence of the
colicin E1-induced current across a planar lipid bilayer on OA con-
centration. The concentration of OA was 10 lM (curve 2) and 30 lM
(curve 3). Curve 1, control in the presence of methyl-b-cyclodextrin at
the same concentration (30 lM) as in curve 3. The membrane was
formed from a squalene solution of DPhPC/DPhPG (70/30%). Initial
voltage, 60 mV. Current is plotted relative to initial conditions.2. Materials and methods
The 178-residue C-terminal colicin E1 channel polypeptide, P178,
was prepared by thermolysin proteolysis of intact colicin E1 [45].
Planar BLMs were formed from a 2% solution of di-
phytanoylphosphatidylcholine/diphytanoylphosphatidylglycerol (DPh-
PC/DPhPG) (70/30 mol%) in squalene by the brush technique [46] on a
0.55-mm diameter hole in a Teﬂon partition separating two compart-
ments of a cell containing aqueous solutions of 120 mM KCl and 10
mM b-alanine, pH 4.0. The electrical current (I) was measured with an
ampliﬁer (U5-11, Moscow, Russia), digitized by a LabPC 1200 (Na-
tional Instruments, Austin, TX) and analyzed using a personal com-
puter with the help of WinWCP Strathclyde Electrophysiology
Software designed by J. Dempster (University of Strathclyde, UK). A
voltage of 60 mV (unless otherwise stated) was applied to BLM with
Ag–AgCl electrodes placed directly into the cell. In single-channel
experiments, a patch-clamp ampliﬁer (model BC-525C, Warner In-
struments, Hamden, CT) was used for current measurements. C-ter-
minal colicin peptide, P178 [45], was added to the cis-side of the
membrane, and myristoyl-lysophosphatidylcholine (M-LPC) and wa-
ter-soluble OA (a complex of OA and methyl-b-cyclodextrin, Sigma)
were added to both sides of the BLM.
Dye-loaded liposomes were prepared by evaporation under a stream
of nitrogen of a 2% solution of a mixture of lipids (Avanti Polar
Lipids, AL) in chloroform followed by hydration with a buﬀer solution
containing 250 mM Tris and 100 mM carboxyﬂuorescein (CF). The
mixture was vortexed, passed through a cycle of freezing and thawing,
and extruded through 0.1-lm pore size Nucleopore polycarbonate
membranes using an Avanti Mini-Extruder. The unbound CF was
then removed by passage through a Sephadex G-50 coarse column
with a buﬀer solution containing 10 mM b-alanine and 0.12 M KCl,
pH 4.0.
Binding of P178 to membranes was monitored using liposomes
containing brominated lipids known to quench tryptophan ﬂuores-
cence [2,47,48]. Liposomes with high 9,10-dibromo-palmi-
toylphosphatidylcholine (9,10-BrPC) content were made from a 2 %
solution of 9,10-BrPC/DPhPG (70/30 mol%) in chloroform. The buﬀer
solution used for preparation of the brominated liposomes contained
10 mM b-alanine and 0.12 M KCl, pH 4.0. The same buﬀer was used in
experiments on tryptophan ﬂuorescence quenching by the brominated
liposomes.
The CF leakage of liposomes was measured with a Hitachi F-4000
(Tokyo, Japan) ﬂuorimeter with peak excitation and emission wave-
lengths of 490 and 520 nm (band-pass of both beams, 5 nm).
The extent of the CF leakage (a) was calculated as follows:
a ð%Þ ¼ 100  ðFf  F0Þ=ðF100  F0Þ, where F0 and Ff represent the ini-
tial and the ﬁnal (steady-state) levels of ﬂuorescence before and after
the protein addition, respectively, and F100 is the ﬂuorescence value
after complete disruption of liposomes by addition of the detergent,
LDAO (lauryldimethylamine-N-oxide, ﬁnal concentration, 2.4% w/w).The b-alanine buﬀer (10 mM b-alanine and 0.12 M KCl, pH 4.0) was
used for the ﬂuorescence studies.
Colicin (P178) was added from a stock water solution to the buﬀer
solution in the spectrophotometric cuvette. M-LPC and OA were ad-
ded to the buﬀer solution containing dye-loaded (measurements of CF
leakage) or brominated (measurements of tryptophan ﬂuorescence
quenching) liposomes in the cuvette. Tryptophan ﬂuorescence excited
at 280 nm was measured at 327 nm (band-pass of both beams, 5 nm).
All experiments were performed at room temperature.3. Results
3.1. Colicin E1 currents across planar lipid bilayers
The eﬀects of M-LPC and OA on the macroscopic current
across BLM mediated by the channel-forming domain of co-
licin E1 (P178) are demonstrated in Fig. 1, panels A and B,
respectively. It is seen that M-LPC induced the increase in the
colicin E1-mediated current, while OA had the opposite eﬀect.
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dence after the addition of both M-LPC and OA (voltage
changes are marked by arrows). It should be noted that the
decrease in the current induced by OA was often preceded by a
transient activation (Fig. 1B). OA was added to the bathing
solution in the form of a complex with cyclodextrin called
‘‘water-soluble OA’’ (complex of OA and methyl-b-cyclo-
dextrin) to provide better delivery and insertion into the
membrane of OA. The control experiments showed that cy-
clodextrin itself did not increase the conductivity of the
membrane and produced no eﬀect on the colicin-induced
current (Fig. 1B, inset, curve 1). The inset to Fig. 1B illustrates
the time courses of the current suppression by increased con-
centrations of OA (curves 2 and 3). The eﬀective concentra-
tions (3–30 lM) were close to those stimulating membrane
fusion mediated by inﬂuenza hemagglutinin (1–10 lM) [33].
Single channels of P178 recorded in DPhPC bilayers at 1 M
KCl exhibit the voltage dependence similar to that character-
istic of the macroscopic current [49]. Fig. 2 illustrates typical
recordings of colicin E1 channels in the control (A) and in theFig. 2. Single-channel traces of colicin E1 (panel A), in the presence of
20 lMM-LPC (panel B) and 30 lMOA (panel C). The membrane was
formed from a decane solution of DPhPC. The buﬀer solution was 10
mM b-alanine and 1 MKCl, pH 4.0. The voltage of 80 mV was applied
to BLM.presence of M-LPC (B) and oleic acid (C). The single-channel
analysis (not shown) revealed that the channel amplitudes re-
mained unaltered after the addition of M-LPC or OA, whereas
the number of open channels diﬀered considerably in the
presence of these agents, increased and decreased, respectively,
in the presence of M-LPC and OA.
3.2. CF leakage from liposomes
The dimensions of pores formed in BLM by antimicrobial
peptides and toxins are so large that they allow the passage of
bulky molecules as CF and calcein [15,16,29,37,38,50–54]. In
this work, colicin E1-induced leakage of CF was measured
from liposomes with diﬀerent membrane curvatures. The ex-
tent of the CF leakage constituted about 17% and depended
slightly on the concentration of P178 within a range 5–40 nM.
In contrast, the rate of the CF leakage, as judged by the half-
time (t1=2) of the time course, rose markedly as the P178 con-
centration was increased from 10 nM (t1=2 ¼ 180 s) to 40 nM
(t1=2 ¼ 10 s), in agreement with earlier data obtained with the
intact colicin E1 protein [55].
Dye-release experiments showed that the rate of the colicin-
induced CF leakage substantially increased in the presence of
M-LPC (Fig. 3), which is consistent with the eﬀect of this SC-
modulating agent on the colicin-induced macroscopic current
(Fig. 1). The half-time for the CF leakage decreased markedly
over a concentration range of 1–10 lM M-LPC at a P178
concentration of 10 nM (Fig. 3, inset). The eﬀective concen-
trations were close to those stimulating membrane fusion
mediated by inﬂuenza hemagglutinin (3–30 lM) [33].
To further test the inﬂuence of membrane SC on the colicin
channel-forming activity, experiments were performed with
liposomes, formed from lipids with diﬀerent SC. Fig. 4A shows
the time courses of the colicin-induced CF leakage of lipo-
somes containing oleoyl-lysophosphatidylcholine (O-LPC)
or dioleoylphosphatidylethanolamine (DOPE) as compared
to that of the control liposomes formed from dioleoyl-
phosphatidylcholine/dioleoylphosphatidylglycerol (DOPC/Fig. 3. The eﬀect of M-LPC on the CF leakage (a denotes the extent of
the CF leakage). The concentration of the DPhPC/DPhPG (70/30%)
liposomes was 10 lM. The concentration of P178 was 5 nM. Curve 1,
control; curves 2–4, M-LPC added at concentrations of 2, 4 and 12
lM, respectively. Inset: Dependence of t1=2 of CF leakage on the
concentration of M-LPC (P178 concentration here was 10 nM).
Fig. 4. CF leakage from liposomes with diﬀerent lipid compositions.
The concentration of P178 was 10 nM, other conditions as in Fig. 2.
(A) O-LPC/DOPC/DOPG (2:5:3), curve 1; DOPC/DOPG (7:3), curve
2; DOPE/DOPG (7:3), curve 3. (B) DPhPC/DPhPG (7:3), curve 1;
DPhPC/DPhPS (7:3), curve 2.
Fig. 5. Binding of colicin E1 to liposomes. Time course of the tryp-
tophan ﬂuorescence quenching by BrPC-containing liposomes. Con-
centrations of P178, 100 nM, and brominated liposomes, 150 lM.
Inset: The extent of quenching of the P178 ﬂuorescence by the
brominated liposomes without additions, in the presence of 15 lM
M-LPC and 20 lM OA, respectively.
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choline having a relatively large polar head group and only one
acyl chain is characterized by a high value of positive SC
[56,57], while DOPE with a small polar head group and two
acyl chains has a high negative SC [57,58]. It is seen that the
colicin-induced CF leakage was accelerated in the presence of
O-LPC (Fig. 4A, curve 1) and decelerated in the presence of
DOPE (Fig. 4A, curve 3) relative to the control (Fig. 4A, curve
2). It should be mentioned that apart from the slow phase, the
time course of the colicin-induced CF leakage of DOPE/
DOPG liposomes contained a fast response that could not be
resolved (Fig. 4A, curve 3). Consistent with the diﬀerence in
the headgroup surface areas of hydrated phosphatidylglycerol
and phosphatidylserine [59], Fig. 4B shows that liposomes
formed from DPhPC/diphytanoylphosphatidylserine (DPhPS)
(7:3) exhibited a slower colicin-induced CF leakage than those
formed from DPhPC/DPhPG (7:3). We note that the surface
areas were compared at higher pH than was used in the present
study and have assumed that the diﬀerence also applies to the
conditions used here. From the comparison of Fig. 4B, curve 1
with Fig. 4A, curve 2, it is evident that the permeabilizing
potency of colicin E1 is reduced in DPhPC/DPhPG compared
to DOPC/DOPG liposomes, in accord with the fact that the
cross-sectional area of the diphytanoyl tail is larger than that
of the dioleoyl tail [60,61]. This conclusion is supported by
corresponding measurements of the colicin E1-mediated cur-
rent with DPhPC/DPhPG and DOPC/DOPG membranes
(data not shown). In addition, experiments were carried out
with cardiolipin, which has more massive fatty acid body.
Cardiolipin did not aﬀect the rate of CF release (not shown),
although it is known to induce negative SC. The reason mightbe that the size of cardiolipin is too large to incorporate in the
toroidal pore.
3.3. Colicin E1 binding to liposomes
It is known that the binding of colicin to membranes is
governed by electrostatics [62] and thus should not be sensitive
to membrane SC. We probed the eﬀect of SC-modulating
agents on the colicin-membrane binding in experiments that
utilized tryptophan ﬂuorescence quenching by brominated
phospholipids. Fig. 5 shows a typical time course of the P178
ﬂuorescence after the addition of liposomes containing 9,10-
BrPC. From the comparison of the corresponding traces of the
ﬂuorescence recorded in the presence of the SC-modulating
agents, it can be concluded that neither M-LPC nor oleic acid
aﬀected the binding of P178 to the lipid bilayer (Fig. 5, inset).
The quenching of colicin tryptophan ﬂuorescence by bromi-
nated phospholipids proceeded much faster than the colicin-
induced CF release from liposomes (compare with Fig. 3).
Upon addition of liposomes to the protein solution, associa-
tion of the channel-forming domain of colicin E1 with the
vesicles is, without stopped-ﬂow-type measurements, appar-
ently instantaneous and thus too fast to be detected by our
present experimental system.4. Discussion
The results of this study have demonstrated the correlation
between the colicin channel-forming activity and membrane
curvature, thereby supporting the hypothesis that channel
formation by colicin E1 occurs via a mechanism involving
toroidal lipidic pore. This mechanism implies direct involve-
ment of lipid headgroups in the formation of the channel wall.
It can be proposed that, in contrast to antimicrobial peptides,
the formation of the colicin E1 channel does not require
oligomerization of the protein, since it has 8 hydrophilic-am-
phypathic and 2 hydrophobic a-helices in its bound state
which should be suﬃcient for the formation of a toroidal pore.
Fig. 6. A scheme of formation of toroidal pore in lipid bilayer induced
by colicin E1. (A) Closed state of pore after colicin binding to mem-
brane or after pore closing in the presence of a trans-positive potential.
(B) Toroidal conﬁguration of the open pore state. Colicin a-helices I–
VII and X are shown in blue, a hairpin of VIII–IX-helices is shown in
brown. Headgroups of neutral lipids are shown in yellow, while those
of anionic lipids are shown in red. Because the anionic lipid involved in
the toroidal channel structure is proposed to be paired with basic
residues in the trans-membrane segments of colicin, it would not
contribute to a net negative charge that would cause a preference of the
channel for cations.
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of 4–7 a-helices, as estimated from neutron-scattering data
[14]. Fig. 6 illustrates a scheme of the toroidal pore formed by
colicin E1. The walls of the pore are made not only of colicin
a-helices (two hydrophobic and four additional helices), but
also of phospholipid molecules intercalated between them.
These lipid molecules experience elastic strain if placed in
highly curved structures. Hence, pore formation should be
facilitated by including lipids with high positive values of SC,
e.g., lysophospholipids.
It is noteworthy that the data on the stimulation of the co-
licin E1 channel-forming activity by lysophosphatidylcholine,
the agent inducing positive SC, apparently explain the stimu-
lating eﬀect of N-bromosuccinimide (NBS) treatment of BLM
on the colicin E1-mediated current observed in [49]. The in-
teraction of NBS with unsaturated phospholipids leads to the
formation of bromohydrins [63] that are suggested to undergo
subsequent hydrolysis of an ester bond, thus producing lyso-
phospholipids similarly to chlorohydrins [64].According to the toroidal pore structure, the phospholipids
in such a pore would exhibit negative curvature in a dimension
parallel to the bilayer plane but positive curvature along the
bilayer normal [17]. Thus, the toroidal pore formation could be
stimulated by lipids characterized by negative SC, as it was
observed with sticholysin [38]. This may explain the transient
stimulation of colicin-induced current after the addition of OA
(Fig. 1).
As mentioned in Section 1, alteration of membrane curvature
results in diﬀerent functional consequences, e.g., modulation of
membrane fusion [33], and regulation of the activity of me-
chanosensitive channels [65,66], sensing of membrane-bending
events by a conserved protein BAR domain that is crucial for
processes of membrane remodeling in growing cells [67], regu-
lation of the assembly/disassembly cycle of the COPI coat on
Golgi membranes [68]. A number of studies have shown that the
agents modifying membrane SC can change the characteristics
of peptidic ion channels. In particular, the addition of lyso-
phospholipids inducing positive membrane curvature causes an
increase in both the number and the lifetime of open gramicidin
channels [69]. Recently, Bruno et al. [70] have demonstrated
that the addition of OA, known to produce the opposite eﬀect
on membrane curvature, also provokes an increase in gramici-
din channel lifetime. Based on these results, the authors came to
the conclusion that the mechanical properties of the bilayer, not
simply curvature, determine the gramicidin channel character-
istics that are associated with hydrophobic mismatch between
the channel length and the bilayer thickness [71].
Keller et al. [72] and Bezrukov et al. [73] observed a corre-
lation between membrane SC and the relative probabilities of
diﬀerent conductance states of alamethicin channels. In par-
ticular, states of higher conductance were more probable in
DOPE, a lipid with high negative curvature, than in DOPC, a
lipid with low curvature. These results were explained in terms
of the ‘‘barrel-stave’’ model by linking a degree of peptide
oligomerization to a membrane-induced line tension [72,74].
According to our measurements, the dependence of colicin E1
single-channel activity on the membrane SC diﬀered substan-
tially from that of alamethicin channels. Modulation of SC led
to alteration of the total number of open channels, but did not
change the distribution of probabilities of low- and high-con-
ductance states.
The dependence of ion selectivity of colicin channels on the
presence of negatively charged lipids in the bilayer [75] can also
be interpreted in terms of direct participation of lipid molecules
in the colicin pore walls or, alternatively as an eﬀect of mem-
brane surface potential. The idea of involvement of lipid mole-
cules in the colicin pore structure has been proposed byKienker
et al. [11]. Actually, the toroidal pore model discussed here
readily explains the ability of pore-forming colicins to translo-
cate their long segments across a membrane [8], by predicting
that the access to the trans-membrane helices of the pore-
forming colicins will be larger than in a pure protein poremodel.
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